ArcticZymes Technologies — Director's Dealing 2017

Jun 2, 2017

Biotec Pharmacon - Mandatory notification of trade

Biotec Pharmacon - Mandatory notification of trade

(Tromsø 02. June 2017) Børge Sørvoll, CFO of Biotec Pharmacon has today

purchased 5.738 shares in Biotec Pharmacon at NOK 6.03 per share. After this

transaction holds Sørvoll 17.428 shares and 82.500 options in Biotec Pharmacon

This information is subject to the disclosure requirements pursuant to section 5

-12 of the Norwegian Securities Trading Act.

For further information, please contact

Børge Sørvoll

CFO

+47 952 90 187

borge.sorvoll@biotec.no